title: Breakthrough of the year 2013. Cancer immunotherapy.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Couzin-Frankel
mesh_terms: D000906:Antibodies / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D060908:CTLA-4 Antigen / Q000037:antagonists & inhibitors* / Q000276:immunology; D002986:Clinical Trials as Topic; D006801:Humans; D007167:Immunotherapy / Q000639:trends*; D000074324:Ipilimumab; D008545:Melanoma / Q000276:immunology / Q000401:mortality / Q000628:therapy; D009369:Neoplasms / Q000276:immunology* / Q000401:mortality / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D000906:Antibodies; D000911:Antibodies, Monoclonal; D060908:CTLA-4 Antigen; D000074324:Ipilimumab